Sandu Pharmaceuticals Ltd has informed that the Board of Directors at their Meeting held on February 14, 2022 have approved incorporation of a wholly owned subsidiary of the Company.
As per regulatory filing, the name of the subsidiary is Sandu Phytoceuticals Private Limited or any other name as may be approved by Ministry of Corporate Affairs. Proposed Authorized Capital is Rs1 lakh only.
Further, the Incorporation of the wholly owned subsidiary will leverage the growth opportunities and will help the Company in becoming more broad based and focused, said company on Monday.
At around 11:30 AM, Sandu Pharmaceuticals was trading at Rs57.10 apiece down by Rs0.45 or 0.78% against its previous closing of Rs57.55 apiece on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
